Related Experiment Video
Updated: Jun 2, 2026
Structured Motor Rehabilitation After Selective Nerve Transfers
Published on: August 15, 2019
Impact of Sensory Re-education Paradigm on Quality of Life, Tactile Sensation, and Proprioceptive Acuity in Patients
Hossam M Alsaid1, Younes A Khadour1, Hoda M Zakaria1
1Department of Physical Therapy for Neurology and Neurosurgery, Faculty of Physical Therapy, Cairo University, Giza, Egypt.
Objectives:
This study evaluated the effect of sensory re-education on quality of life and sensation in patients with post-COVID-19 polyneuropathy.
Methods:
Forty patients with post-COVID-19 polyneuropathy were randomly assigned to a study group (Group A) or a control group (Group B), each with 20 participants. Group A received a sensory re-education protocol plus the traditional physiotherapy, including proprioceptive neuromuscular facilitation (PNF) and strengthening exercises for wrist extensors, hand grip, and thumb opposition. Group B received the traditional physiotherapy alone. Both groups were treated for one hour, three times weekly, for six weeks. Quality of life was assessed using the Arabic WHOQOL-BREF. Tactile sensation was assessed using the Semmes-Weinstein Monofilament (SWM) test, and proprioception via the laser-pointer angle reproduction test (LP-ART). Assessments were performed pre- and post-intervention.
Results:
Both groups showed significant pre- to post-treatment improvements in quality of life, proprioception, and tactile sensation (p≤ 0.05). Group A demonstrated significantly greater gains in quality of life and proprioception compared to Group B (p≤ 0.05), but no statistically significant difference between groups in tactile sensation (p> 0.05).
Conclusion:
Sensory re-education, when integrated into traditional physiotherapy, significantly improves quality of life and proprioception in post-COVID-19 polyneuropathy but does not significantly affect tactile sensation. These findings support incorporating sensory re-education into rehabilitation protocols to enhance functional outcomes in this population.
Clinicaltrials:
gov ID: NCT05911113.
